Careful though. This research is provided by the broker that manager the reverse takeover, so the pure objectivity might not be there. Also, a target of $0.49? It sounds like they thought "ah, just double the current sale price" was going to be perceived as a bit on the nose, so they dropped it by 1c.
I like the look of these guys, and I'm extremely excited about the march into other continents. I'm just a bit skeptical about how awesome this research is presenting the company.
- Forums
- ASX - By Stock
- Ann: Baker Young Research Report
Careful though. This research is provided by the broker that...
Featured News
Add CWL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online